The role of pyroptosis-related genes in the diagnosis and subclassification of sepsis

PLoS One. 2023 Nov 8;18(11):e0293537. doi: 10.1371/journal.pone.0293537. eCollection 2023.

Abstract

Pyroptosis is a new form of programmed cell death recognized as crucial in developing sepsis. However, there is limited research on the mechanism of pyroptosis-related genes in sepsis-related from the Gene Expression Omnibus (GEO) database and standardized. The expression levels of pyroptosis-related genes were extracted, and differential expression analysis was conducted. A prediction model was constructed using random forest (RF), support vector machine (SVM), weighted gene co-expression new analysis (WGCNA), and nomogram techniques to assess the risk of sepsis. The relationship between pyroptosis-related subgroups and the immune microenvironment and inflammatory factors was studied using consistent clustering algorithms, principal component analysis (PCA), single-sample genomic enrichment analysis (ssGSEA), and immune infiltration. A risk prediction model based on 3 PRGs has been constructed and can effectively predict the risk of sepsis. Patients with sepsis can be divided into two completely different subtypes of pyroptosis-related clusters. Cluster B is highly correlated with the lower proportion of Th17 celld and has lower levels of expression of inflammatory factors. This study utilizes mechanical learning methods to further investigate the pathogenesis of sepsis, explore potential biomarkers, provide effective molecular targets for its diagnosis and treatment of sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Apoptosis
  • Cluster Analysis
  • Humans
  • Pyroptosis* / genetics
  • Sepsis* / diagnosis
  • Sepsis* / genetics

Grants and funding

This study was funded by 1. The Foshan City "14th Five-Year Plan" Traditional Chinese Medicine Specialty Construction Project (TSZKJS22), 2.The Foshan City "14th Five-Year Plan" High Level Medical Key Specialty Construction Project (FSGSP145083), 3. Foshan Traditional Chinese Medicine Immune Health Technology Innovation Base.